About SubjectWell
SubjectWell is a Healthcare company based in Austin (United States) founded in 2012, and was acquired by WindRose Health Investors in April 2024. Clinical trials marketplace for patient recruitment solutions is provided. SubjectWell has raised $46.8 million across 3 funding rounds from investors including Asset Management Ventures, Bertelsmann Investments and Windham Capital Partners. SubjectWell has completed 2 acquisitions, including PatientCentra and Trials24. Its chief executive, as recorded, is Fred Martin. SubjectWell offers products and services including SubjectWell+ Platform, Study Connect, Direct Connect, Brand Connect, and Virtual Waiting Room. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Evidation, Dyania Health and Clara Health; 3 of its 3 listed competitors have raised funding.
Company details
SubjectWell was founded in 2012 in Austin, United States, within the health technology sector. A platform is operated to identify and engage patients interested in clinical trials, facilitating introductions and alerts to relevant opportunities. Quality referrals are ensured through prescreening processes, supporting recruitment efforts for trial sponsors across the United States.
- Headquarters Austin, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website subjectwell.com
- Social LinkedIn X
- Acquired by WindRose Health Investors (Apr 2024)
- Total Equity Funding$46.8M (USD)
in 3 rounds
- Latest Funding Round$35M (USD), Series B
Oct 2022
- InvestorsAsset Management Ventures
& 5 more
- Investments & AcquisitionsPatientCentra
& 1 more
- Acquired byWindRose Health Investors
(Apr 2024)
Products & Services of SubjectWell
SubjectWell offers a comprehensive portfolio of products and services, including SubjectWell+ Platform, Study Connect, Direct Connect, Brand Connect, and Virtual Waiting Room.
Technology for managing clinical trial recruitment and site enablement.
Connects patients to clinical studies efficiently.
Facilitates direct patient enrollment in trials.
Supports marketing and patient engagement for brands.
Keeps patients engaged before trial participation.
Funding Insights of SubjectWell
SubjectWell has successfully raised a total of $46.8M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $35 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $46.8M
- Total Rounds 3
- Last Round Series B — $35M
- First Round $1.8M
(Feb 2018)
- Investors Count 5
All 3 funding rounds of SubjectWell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $35M | Series B | – | Asset Management Ventures | |
| Jun 2019 | $10M | Series A | – | Windham Venture Partners | |
| Feb 2018 | $1.8M | Seed | – | – |
6 investors in total: 6 institutional.
Investors in SubjectWell
SubjectWell has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Asset Management Ventures, Bertelsmann Investments and Windham Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage US companies are invested in by Asset Management Ventures. | assetman.com | Palo Alto, United States | ||
Venture capital fund investing in multiple sectors | bertelsmann-investments.com | Gutersloh, Germany | ||
Venture capital funding is provided to early-stage startups. | geekdomfund.com | |||
Seed-stage investments in US tech sectors are targeted. | healthy.vc | San Francisco, United States | ||
US healthcare investments are managed by private equity firm. | windrose.com | New York, United States | ||
Windham Capital Partners is focused on HealthTech venture investments. | windhamvp.com | New York, United States |
Investor details for SubjectWell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SubjectWell
25 people are tracked at SubjectWell (12 in leadership, 2 in board & advisors, 11 in team).
| Name | Role | Group |
|---|---|---|
Fred Martin | CEO | Leadership |
Dana Ennis | Vice President Sales, Strategic Accounts | Leadership |
Grant Weaver | Director Data Revenue Operations | Leadership |
Nick Elvis | Chief Commercial Officer | Leadership |
Simone Anell | Director Business Development - Europe | Leadership |
Danielle Mann | Vice President Of Legal & Compliance, Data Privacy Officer | Leadership |
Camy Moodley | Managing Director | Leadership |
Karl Stubelis | Chief Financial Officer | Leadership |
Ken Wallace | Vice President Of Sales | Leadership |
Tammi Acord | Vice President Of Sales | Leadership |
James Rucki | Executive Director, Commercial Sales | Leadership |
Steve Ciske | Chief Technology Officer | Leadership |
Enmi Kendall | Board Member | Board & advisors |
Adam Fine | Board Member | Board & advisors |
Kayla Oswald | Affiliate And Partnerships Manager | Team |
Timothy Dinkins | Software Engineering Manager | Team |
Robert Bolt | QA Engineer | Team |
Mario E. González | Account Manager | Team |
Antwan D. | Software QA Engineer | Team |
Thomas W. | Lead Data Analyst | Team |
5 more people are available in the full profile.
Complete people profiles for SubjectWell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SubjectWell
SubjectWell has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include PatientCentra and Trials24.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Patient recruitment and engagement platform for clinical trials is provided. | trials24.com | Munich, Germany | 2017 | Sep 2024 | •••• | |
Customized clinical trial patient recruitment solutions are provided globally. | patientcentra.com | Waltham, United States | 2013 | Nov 2023 | •••• |
Complete acquisition details for SubjectWell
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SubjectWell
6 dated milestones of SubjectWell across 12 years, from founding to its latest funding, stage changes and deals.
- Founded SubjectWell is founded.
- Funding First funding round of $1.8M.
- Funding Latest funding round, Series B, of $35.0M.
- Acquisition Acquires PatientCentra.
- Exit Acquired by WindRose Health Investors.
- Acquisition Acquires Trials24.
Competitors of SubjectWell
SubjectWell has 3 listed competitors in our database, 3 of them funded. They include Evidation, Dyania Health and Clara Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evidation.com | 2012 | Menlo Park, United States | $259.16M | 196 | Real-world health data is provided for research and decisions. | |
| dyaniahealth.com | 2019 | Sacramento, United States | $15.3M | Patients for clinical trials are identified through a dedicated platform. | ||
| clarahealth.com | 2015 | Boston, United States | $18.19M | 36 | Clinical trials are matched to patients via an online platform. |
Detailed competitors of SubjectWell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SubjectWell
The website of SubjectWell (subjectwell.com) receives about 5.1K visits a month and ranks #3,457,861 among all websites worldwide, #4,501 in Biotechnology and Pharmaceuticals.
- Monthly visits5.1K
▼ 4.7% vs previous month
- Unique visitors2.4K
per month
- Global rank#3,457,861
among all websites
- Category rank#4,501
Health · Biotechnology and Pharmaceuticals
- Bounce rate33%
- Pages per visit1.9
- Average visit14 sec
- DevicesDesktop 23% · Mobile 77%
Websites whose visitors overlap most with SubjectWell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| credevo.com | 100% | 13K | #2,544,661 | View details | |
| patientwing.com | 89% | 33.2K | #1,029,837 | View details | |
| obviohealth.com | 70% | 11.2K | #2,240,692 | View details | |
acrpnet.org | acrpnet.org | 63% | #507,004 | – | |
| sanogenetics.com | 63% | 23.6K | #1,140,315 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for SubjectWell
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as SubjectWell (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Subjectwell
Complete news archive for SubjectWell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SubjectWell
SubjectWell was founded in 2012 and raised its 1st funding round 6 years after it was founded.
SubjectWell is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Fred Martin is the CEO of SubjectWell, as recorded in our data.
SubjectWell is a funded company, having raised a total of $46.8M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.8M, raised on Feb 2018.
SubjectWell was founded in 2012 in Austin, United States, within the health technology sector. A platform is operated to identify and engage patients interested in clinical trials, facilitating introductions and alerts to relevant opportunities. Quality referrals are ensured through prescreening processes, supporting recruitment efforts for trial sponsors across the United States.
SubjectWell's top competitors include Evidation, Dyania Health and Clara Health.
SubjectWell offers SubjectWell+ Platform, Study Connect, Direct Connect, Brand Connect, and Virtual Waiting Room.
SubjectWell has made 2 acquisitions, including PatientCentra, and Trials24.
SubjectWell has 6 investors. Key investors include Asset Management Ventures, Bertelsmann Investments, Windham Capital Partners, Geekdom Fund, and Healthy Ventures.
Yes. SubjectWell was acquired by WindRose Health Investors in April 2024.